Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
[PDF][PDF] Potentiation of calcium-activated chloride secretion and barrier dysfunction may underlie
Y Kim, A Quach, S Das - Physiological reports, 2020 - scholar.archive.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are firstline therapies
for various cancers, and cause dose-limiting severe diarrhea in many patients. We …
for various cancers, and cause dose-limiting severe diarrhea in many patients. We …
[HTML][HTML] Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea
Y Kim, A Quach, S Das, KE Barrett - Physiological Reports, 2020 - ncbi.nlm.nih.gov
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea
Y Kim, A Quach, S Das, KE Barrett - Physiological Reports, 2020 - search.proquest.com
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
[引用][C] Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor‐induced diarrhea
Y Kim, A Quach, S Das, KE Barrett - Physiological Reports, 2020 - cir.nii.ac.jp
Potentiation of calcium‐activated chloride secretion and barrier dysfunction may underlie EGF
receptor tyrosine kinase inhibitor‐induced diarrhea | CiNii Research CiNii 国立情報学研究所 …
receptor tyrosine kinase inhibitor‐induced diarrhea | CiNii Research CiNii 国立情報学研究所 …
Potentiation of calcium-activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor-induced diarrhea.
Y Kim, A Quach, S Das, KE Barrett - Physiological Reports, 2020 - europepmc.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFr TKIs) are first‐line
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …
therapies for various cancers, and cause dose‐limiting severe diarrhea in many patients. We …